Compare
Modular Medical, Inc. vs Sonoma Pharmaceuticals, Inc. vs Allurion Technologies, Inc. vs IceCure Medical Ltd.
| Latest fiscal year | Modular Medical, Inc. MODD | Sonoma Pharmaceuticals, Inc. SNOA | Allurion Technologies, Inc. ALUR | IceCure Medical Ltd. ICCM |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $19.53M | $15.23M | $3.38M |
| Revenue growth (YoY) | n/a | +36.7% | -52.6% | +2.7% |
| Gross margin | n/a | 38.0% | 62.8% | 36.3% |
| Operating margin | n/a | -12.6% | -198.0% | -446.7% |
| Net margin | n/a | -16.3% | -188.8% | -445.6% |
| Net income | -$28.24M | -$3.17M | -$28.75M | -$15.06M |
| EPS (Diluted) | -$12.36 | -$1.89 | -$3.81 | $0.24 |
| Operating cash flow | -$23.75M | -$3.93M | -$28.95M | -$14.57M |
| Free cash flow | -$27.68M | -$4.12M | n/a | -$14.61M |
| Cash & equivalents | $6.94M | $2.40M | $5.41M | $8.90M |
| Total assets | $14.83M | $13.96M | $15.77M | $13.89M |
| Total liabilities | $1.87M | $10.87M | $92.96M | n/a |
| Shareholders' equity | $12.96M | $3.10M | -$77.19M | $9.05M |
| Return on year-end equity | -217.9% | -102.6% | n/a | -166.4% |
| Shares outstanding | 4.66M | 1.80M | 12.28M | 73.12M |
Revenue, most recent five fiscal years
| Fiscal year | Modular Medical, Inc. | Sonoma Pharmaceuticals, Inc. | Allurion Technologies, Inc. | IceCure Medical Ltd. |
|---|---|---|---|---|
| Latest | $0 Ended 2018-03-31 | $19.53M Ended 2026-03-31 | $15.23M Ended 2025-12-31 | $3.38M Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2017-03-31 | $14.29M Ended 2025-03-31 | $32.11M Ended 2024-12-31 | $3.29M Ended 2024-12-31 |
| 2 years earlier | n/a | $12.73M Ended 2024-03-31 | $53.47M Ended 2023-12-31 | $3.23M Ended 2023-12-31 |
| 3 years earlier | n/a | $13.27M Ended 2023-03-31 | $64.21M Ended 2022-12-31 | $3.08M Ended 2022-12-31 |
| 4 years earlier | n/a | $12.63M Ended 2022-03-31 | n/a | $4.14M Ended 2021-12-31 |